Adynxx
is a clinical-stage pharmaceutical company that focuses on developing pain management drugs... Read moreAdynxx
is a clinical-stage pharmaceutical company that focuses on developing pain management drugs... Read more
President & CEO
Rick Orr
News
Mar 20, 2020
MarketScreener
Adynxx: Adynxx : SEC Filing (15-12B) - Securities Registration Termination
Nov 14, 2019
Seeking Alpha
Adynxx: Adynxx reports Q3 results
Oct 11, 2019
SEC
Adynxx: ADYNXX, INC. - S1 File
Oct 02, 2019
GlobeNewswire
Press Release: Adynxx : Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic
Aug 22, 2019
MarketScreener
Adynxx: Adynxx : Amended Registration statement for face-amount certificate companies
Aug 14, 2019
MarketScreener
Adynxx: Adynxx Reports Second Quarter 2019 Financial Results
Aug 13, 2019
MarketScreener
Adynxx: Adynxx : DEF 14C
Jul 22, 2019
Benzinga
Adynxx: Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market
Jul 18, 2019
4-traders
Adynxx: OTC Markets : Welcomes New OTCQB Companies -July 18
Jun 26, 2019
4-traders
Adynxx: Adynxx : Report of unscheduled material events or corporate event
Adynxx Competitors
1
2
3
4
5
6
7
8
9
10